CN103816492A - Chinese medicinal composition for treating atrophic gastritis - Google Patents
Chinese medicinal composition for treating atrophic gastritis Download PDFInfo
- Publication number
- CN103816492A CN103816492A CN201410107016.2A CN201410107016A CN103816492A CN 103816492 A CN103816492 A CN 103816492A CN 201410107016 A CN201410107016 A CN 201410107016A CN 103816492 A CN103816492 A CN 103816492A
- Authority
- CN
- China
- Prior art keywords
- parts
- parched
- brown
- fructus
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition for treating atrophic gastritis. The Chinese medicinal composition comprises the following Chinese medicinal raw materials in parts by weight: 10-40 parts of largehead atractylodes rhizome, 5-25 parts of nutgrass galingale rhizome, 5-20 parts of fructus amomi, 5-25 parts of codonopsis pilosula, 5-20 parts of turmeric root-tuber, 5-25 parts of dendrobium stem, 5-25 parts of bletilla striata, 5-20 parts of poria, 5-25 parts of cape jasmine fruit, 5-20 parts of caulis perllae, 5-25 parts of scorched hawthorn fruit, 5-25 parts of scorched medicated leaven, 5-25 parts of scorched barley sprout, 5-20 parts of bamboo shavings, 5-25 parts of tangerine peel, 5-20 parts of golden thread, 5-25 parts of green tangerine peel and 5-15 parts of licorice root. The Chinese medicinal composition disclosed by the invention has effects on invigorating the spleen to nourish qi, tonifying the stomach to promote fluid, improving digestion to promote granulation, clearing away heat and toxic materials and promoting blood circulation to remove blood stasis, has a significant effect on treating the atrophic gastritis, and is reliable in effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical product of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of atrophic gastritis.
Background technology
Atrophic gastritis refers to the intrinsic body of gland atrophy of mucosa causing after gastric mucosa surface suffers damage repeatedly, even disappears, and the common pathological change thickening of muscular layer of mucosa.Due to body of gland atrophy or disappearance, gastric mucosa has attenuation in various degree, and often with intestinal epithelial metaplasia, inflammatory reaction and atypical hyperplasia.This disease is one of digestive system common disease, and in China's population, the sickness rate of chronic gastritis is very high, and wherein atrophic gastritis accounts for 13.8% of the number examined.Atrophic gastritis is take protracted inflammation, long-term dyspepsia as feature, and main manifestations is abdominal distention, and abdominal distention is more obvious for polyphagia a little, tastelessness, and gastral cavilty portion dull pain discomfort, tired, become thin, poor appetite, anemia etc.At present, the treatment of atrophic gastritis is mainly adopted to protection gastric mucosa, anti-helicobacter pylori, enhancing gastric motility, and the symptomatic treatment such as pain relieving, its medicine has: gastric mucosal protection medicine, digestant, anti helicobacter pylori medicine, H2 receptor antagonist etc.Although these medicines can improve some clinical symptoms, exist treatment time long, the deficiency that curative effect is not obvious and side effect is large.
The traditional Chinese medical science thinks, weakness of the spleen and stomach, obstruction of QI are the basic pathology mechanism of atrophic gastritis.Old cloudy lose, internal injury caused by excess of seven emotions, diet accumulation of phlegm, prolonged illness causes stasis of blood factors all can make spleen and stomach function impaired, lifting is unable, mechanism of qi operation is not smooth, and presents gastral cavilty portion distension, dull pain, poor appetite, the symptom such as weak.Primary disease belongs to the card of deficiency in origin and excess in superficiality, coldheat complex, and as this, just more empty heresy is more tied take weakened body resistance, and heresy is more tied just more empty, often interacts, and is difficult to speed more.
According to theory of Chinese medical science, for the pathogeny of atrophic gastritis, take invigorating the spleen and benefiting QI, reinforcing stomach reg fluid, the granulation promoting that helps digestion as the rule for the treatment of, carry out dialectical composition of prescription, to reach treating both the principal and secondary aspects of a disease object.
Summary of the invention
Exist treatment time long in order to overcome available technology adopting western medicine atrophic gastritis, the deficiency that curative effect is not obvious and side effect is large, the invention provides a kind of prepare easy, cost is low, the Chinese medicine composition of evident in efficacy, the treatment atrophic gastritis that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of atrophic gastritis, is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Rhizoma Atractylodis Macrocephalae 10-40 part, Rhizoma Cyperi 5-25 part, Fructus Amomi 5-20 part, Radix Codonopsis 5-25 part, Radix Curcumae 5-20 part, Herba Dendrobii 5-25 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 5-25 part, Poria 5-20 part, Fructus Gardeniae 5-25 part, Caulis Perillae 5-20 part, Fructus Crataegi (parched to brown) 5-25 part, Massa Medicata Fermentata (parched to brown) 5-25 part, Fructus Hordei Germinatus (parched to brown) 5-25 part, Caulis Bambusae In Taenia 5-20 part, Pericarpium Citri Reticulatae 5-25 part, Rhizoma Coptidis 5-20 part, Pericarpium Citri Reticulatae Viride 5-25 part, Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of atrophic gastritis, is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 25 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Rhizoma Cyperis, 10 parts of Fructus Amomis, 15 parts of Radix Codonopsis, 10 parts of Radix Curcumaes, 15 parts of Herba Dendrobiis, 15 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 10 parts of Poria, 15 parts of Fructus Gardeniaes, 10 parts of Caulis Perillaes, 15 parts of Fructus Crataegi (parched to brown)s, 15 parts of Massa Medicata Fermentata (parched to brown), 15 parts of Fructus Hordei Germinatus (parched to brown)s, 10 parts of Caulis Bambusae In Taenia, 15 parts of Pericarpium Citri Reticulataes, 10 parts of Rhizoma Coptidis, 15 parts, Pericarpium Citri Reticulatae Viride, 10 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: the Rhizoma Atractylodis Macrocephalae has invigorating the spleen and benefiting QI, dampness diuretic, the antiabortive effect of hidroschesis; Rhizoma Cyperi has effect of liver-smoothing, qi-regulating, resolving depression pain relieving; Fructus Amomi has removing dampness appetizing, warming spleen and stopping diarrha, the antiabortive effect of regulating the flow of vital energy; Radix Codonopsis has effect of invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; Radix Curcumae has effect of regulating qi to disperse stagnation, heart fire-clearing upset-relieving; Herba Dendrobii has effect of reinforcing stomach reg fluid, nourishing YIN and clearing away heat; The Pseudobulbus Bletillae (Rhizoma Bletillae) has effect of astringing to arrest bleeding, detumescence and promoting granulation; Poria has benefiting vital QI for tranquillizing, invigorating the spleen and regulating the stomach, dispels effect damp and hot, row water stopping leak; Fructus Gardeniae has effect of pathogenic fire purging relieving restlessness, clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body; Caulis Perillae has effect of regulating the flow of QI to ease the stomach, relieving the exterior syndrome by diaphoresis; Fructus Crataegi (parched to brown) has effect of promoting digestion and invigorating the stomach, blood circulation promoting and blood stasis dispelling, convergence dysentery relieving; Effect that Massa Medicata Fermentata (parched to brown) has invigorating the spleen and regulating the stomach, helps digestion in adjusting; Fructus Hordei Germinatus (parched to brown) has promote qi circulation digestion promoting, spleen benefiting and stimulating the appetite, moves back effect of newborn relieving distension; Caulis Bambusae In Taenia has effect of clearing away heat-fire, clearing away phlegm removing heat from blood, relieving restlessness dissipating depression of QI; Pericarpium Citri Reticulatae has effect of diuretic, drying dampness to eliminate phlegm in regulating qi-flowing for strengthening spleen, tune; Rhizoma Coptidis has effect of heat clearing and damp drying, eliminating fire and detoxication; Pericarpium Citri Reticulatae Viride has soothing the liver dispelling the stagnated QI, the stagnant effect of removing food stagnancyization; Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component is through dialectical compatibility, helps using mutual assistant, plays altogether invigorating the spleen and benefiting QI, reinforcing stomach reg fluid, effect of the granulation promoting that helps digestion, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, and the treatment of atrophic gastritis is reached to treating both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, does not occur toxic and side effects, and effective percentage reaches 92%, cure rate 68%.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for atrophic gastritis, its raw material of Chinese medicine and weight proportion are: Rhizoma Atractylodis Macrocephalae 25g, Rhizoma Cyperi 15g, Fructus Amomi 10g, Radix Codonopsis 15g, Radix Curcumae 10g, Herba Dendrobii 15g, Pseudobulbus Bletillae (Rhizoma Bletillae) 15g, Poria 10g, Fructus Gardeniae 15g, Caulis Perillae 10g, Fructus Crataegi (parched to brown) 15g, Massa Medicata Fermentata (parched to brown) 15g, Fructus Hordei Germinatus (parched to brown) 15g, Caulis Bambusae In Taenia 10g, Pericarpium Citri Reticulatae 15g, Rhizoma Coptidis 10g, Pericarpium Citri Reticulatae Viride 15g, Radix Glycyrrhizae 10g.
Embodiment 2
Treat a Chinese medicine composition for atrophic gastritis, its raw material of Chinese medicine and weight proportion are: Rhizoma Atractylodis Macrocephalae 15g, Rhizoma Cyperi 25g, Fructus Amomi 5g, Radix Codonopsis 20g, Radix Curcumae 12g, Herba Dendrobii 25g, Pseudobulbus Bletillae (Rhizoma Bletillae) 5g, Poria 20g, Fructus Gardeniae 10g, Caulis Perillae 15g, Fructus Crataegi (parched to brown) 5g, Massa Medicata Fermentata (parched to brown) 25g, Fructus Hordei Germinatus (parched to brown) 10g, Caulis Bambusae In Taenia 20g, Pericarpium Citri Reticulatae 5g, Rhizoma Coptidis 15g, Pericarpium Citri Reticulatae Viride 5g, Radix Glycyrrhizae 12g.
Embodiment 3
Treat a Chinese medicine composition for atrophic gastritis, its raw material of Chinese medicine and weight proportion are: Rhizoma Atractylodis Macrocephalae 30g, Rhizoma Cyperi 10g, Fructus Amomi 20g, Radix Codonopsis 5g, Radix Curcumae 15g, Herba Dendrobii 10g, Pseudobulbus Bletillae (Rhizoma Bletillae) 20g, Poria 5g, Fructus Gardeniae 25g, Caulis Perillae 12g, Fructus Crataegi (parched to brown) 20g, Massa Medicata Fermentata (parched to brown) 5g, Fructus Hordei Germinatus (parched to brown) 25g, Caulis Bambusae In Taenia 12g, Pericarpium Citri Reticulatae 5g, Rhizoma Coptidis 20g, Pericarpium Citri Reticulatae Viride 10g, Radix Glycyrrhizae 8g.
Embodiment 4
Treat a Chinese medicine composition for atrophic gastritis, its raw material of Chinese medicine and weight proportion are: Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Cyperi 20g, Fructus Amomi 12g, Radix Codonopsis 25g, Radix Curcumae 5g, Herba Dendrobii 20g, Pseudobulbus Bletillae (Rhizoma Bletillae) 10g, Poria 15g, Fructus Gardeniae 5g, Caulis Perillae 20g, Fructus Crataegi (parched to brown) 10g, Massa Medicata Fermentata (parched to brown) 20g, Fructus Hordei Germinatus (parched to brown) 5g, Caulis Bambusae In Taenia 15g, Pericarpium Citri Reticulatae 10g, Rhizoma Coptidis 5g, Pericarpium Citri Reticulatae Viride 25g, Radix Glycyrrhizae 5g.
Embodiment 5
Treat a Chinese medicine composition for atrophic gastritis, its raw material of Chinese medicine and weight proportion are: Rhizoma Atractylodis Macrocephalae 40g, Rhizoma Cyperi 5g, Fructus Amomi 15g, Radix Codonopsis 10g, Radix Curcumae 20g, Herba Dendrobii 5g, Pseudobulbus Bletillae (Rhizoma Bletillae) 25g, Poria 12g, Fructus Gardeniae 20g, Caulis Perillae 5g, Fructus Crataegi (parched to brown) 25g, Massa Medicata Fermentata (parched to brown) 10g, Fructus Hordei Germinatus (parched to brown) 20g, Caulis Bambusae In Taenia 5g, Pericarpium Citri Reticulatae 25g, Rhizoma Coptidis 12g, Pericarpium Citri Reticulatae Viride 20g, Radix Glycyrrhizae 15g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and cover powder, soak 15～20 minutes, then add water and do not have approximately 6 centimetres of powder, decoct for the first time, adopt intense fire to decoct before at a simmer, after boiling with slow fire boiling 20～30 minutes; Decoct for the second time, add water and do not have approximately 4 centimetres of powder, after water boils, decoct 15～20 minutes.Decoct extracting juice twice, merge.
The present invention, with the given a kind of Chinese medicine composition for the treatment of atrophic gastritis of embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 50 examples, male 28 examples, female's 22 examples, 35～75 years old age.
Two, diagnosis basis: epigastric discomfort or pain after feed, show as irregular persistence epigastrium pain, or have inappetence, feel sick, abdominal distention belch, tired, become thin, suffer from diarrhoea, the how light or extra dry red wine no fur of body of the tongue.
Three, usage and dosage: when clinical practice, potion on the one, the about 400ml of twice extracting juice of decocting, point morning, late twice decoction being taken warmly.It within six days, is a course for the treatment of.Avoid cold and uncooked food during the treatment thing of pungent stimulation.
Four, criterion of therapeutical effect:
(1), recovery from illness: clinical symptoms and sign disappear, and appetite is normal;
(2), effective: clinical symptoms and sign disappear substantially, and appetite is improved;
(3), effective: clinical symptoms and sign obviously alleviate, but still leave over a part of symptom;
(4), invalid: clinical symptoms and sign are slightly improved or without improvement.
Five, therapeutic effect: in this clinical observation case, take medicine 4-8 the course for the treatment of, recovery from illness 34 examples, follow up a case by regular visits to and have no recurrence; Effective 8 examples, effective 4 examples, invalid 4 examples.During treatment, there is not toxic and side effects.
Six, model case:
Case 1:
Normal certain, man, 47 years old.Patient's readme: often gastral cavilty calcination, inappetence, feel sick, abdominal distention belch, tired, become thin, suffer from diarrhoea.Diagnosis: atrophic gastritis.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, all symptoms are eased; Continue to take 3 courses for the treatment of, health complete recovery of health.
Case 2:
Poplar, female, 54 years old.When medical: upper abdomen distending pain, anti-sour ﹑ gas ﹑ beats belch ﹑ and receives weak 2 years of poor ﹑, within nearly two months, increases the weight of in year.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, Shang abdomen Teng Tong ﹑ flatulence disappears, and appetite increases, and health is strong, anti-Suan ﹑ Ai Qi ﹑ xerostomia etc., and malaise symptoms disappears; Continue to strengthen treatment and take 3 courses for the treatment of, recovery from illness; Follow up a case by regular visits to and have no recurrence half a year.
Case 3:
Yao, man, 39 years old.Private prosecution when medical: because diet is irregular, drink, have a stomach-ache, have the hiccups, glutted, stomachache, diarrhoea and constipation after the meal replace, inappetence, with bitter taste.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, have a stomach-ache, have the hiccups, the clinical symptom disappearance such as glutted after the meal; Continue to strengthen to take and treat 3 courses for the treatment of, recovery from illness.
Claims (2)
1. a Chinese medicine composition for the treatment of atrophic gastritis, is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Rhizoma Atractylodis Macrocephalae 10-40 part, Rhizoma Cyperi 5-25 part, Fructus Amomi 5-20 part, Radix Codonopsis 5-25 part, Radix Curcumae 5-20 part, Herba Dendrobii 5-25 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 5-25 part, Poria 5-20 part, Fructus Gardeniae 5-25 part, Caulis Perillae 5-20 part, Fructus Crataegi (parched to brown) 5-25 part, Massa Medicata Fermentata (parched to brown) 5-25 part, Fructus Hordei Germinatus (parched to brown) 5-25 part, Caulis Bambusae In Taenia 5-20 part, Pericarpium Citri Reticulatae 5-25 part, Rhizoma Coptidis 5-20 part, Pericarpium Citri Reticulatae Viride 5-25 part, Radix Glycyrrhizae 5-15 part.
2. a kind of Chinese medicine composition for the treatment of atrophic gastritis according to claim 1, is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 25 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Rhizoma Cyperis, 10 parts of Fructus Amomis, 15 parts of Radix Codonopsis, 10 parts of Radix Curcumaes, 15 parts of Herba Dendrobiis, 15 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 10 parts of Poria, 15 parts of Fructus Gardeniaes, 10 parts of Caulis Perillaes, 15 parts of Fructus Crataegi (parched to brown)s, 15 parts of Massa Medicata Fermentata (parched to brown), 15 parts of Fructus Hordei Germinatus (parched to brown)s, 10 parts of Caulis Bambusae In Taenia, 15 parts of Pericarpium Citri Reticulataes, 10 parts of Rhizoma Coptidis, 15 parts, Pericarpium Citri Reticulatae Viride, 10 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410107016.2A CN103816492A (en) | 2014-03-21 | 2014-03-21 | Chinese medicinal composition for treating atrophic gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410107016.2A CN103816492A (en) | 2014-03-21 | 2014-03-21 | Chinese medicinal composition for treating atrophic gastritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103816492A true CN103816492A (en) | 2014-05-28 |
Family
ID=50751972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410107016.2A Pending CN103816492A (en) | 2014-03-21 | 2014-03-21 | Chinese medicinal composition for treating atrophic gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103816492A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102274466A (en) * | 2011-08-15 | 2011-12-14 | 荣成市商贸城卫生所 | Chinese medicinal composition for treating gastritis |
| CN102861298A (en) * | 2012-10-18 | 2013-01-09 | 林强 | Traditional Chinese medicine composition for treating chronic gastritis |
| CN103007206A (en) * | 2013-01-16 | 2013-04-03 | 李郑生 | Oral liquid for treating chronic atrophic gastritis |
| CN103041333A (en) * | 2012-12-21 | 2013-04-17 | 孙红梅 | Traditional Chinese medicine composition for treating gastritis |
-
2014
- 2014-03-21 CN CN201410107016.2A patent/CN103816492A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102274466A (en) * | 2011-08-15 | 2011-12-14 | 荣成市商贸城卫生所 | Chinese medicinal composition for treating gastritis |
| CN102861298A (en) * | 2012-10-18 | 2013-01-09 | 林强 | Traditional Chinese medicine composition for treating chronic gastritis |
| CN103041333A (en) * | 2012-12-21 | 2013-04-17 | 孙红梅 | Traditional Chinese medicine composition for treating gastritis |
| CN103007206A (en) * | 2013-01-16 | 2013-04-03 | 李郑生 | Oral liquid for treating chronic atrophic gastritis |
Non-Patent Citations (2)
| Title |
|---|
| 曹连春等: "慢性萎缩性胃炎中西医结合治疗进展", 《现代中西医结合杂志》 * |
| 杨万刚: "中西医结合治疗慢性萎缩性胃炎临床观察", 《北京中医药大学学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102861298B (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN102430092B (en) | Traditional Chinese medicine composite for treating stomach cold and stomachache | |
| CN103463587B (en) | A kind of Chinese medicine composition for the treatment of Deficiency and coldness of spleen and stomach | |
| CN103316279B (en) | Traditional Chinese medicine composition for treating chronic gastroenteritis | |
| CN104107387A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN104623598A (en) | Traditional Chinese medicine composition for treating deficiency-cold in spleen and stomach | |
| CN103356989A (en) | Traditional Chinese medicine composition for treating incoordination between spleen and stomach | |
| CN103736061A (en) | Traditional Chinese medicine composition for treating stomach distension | |
| CN104771707A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN104667126A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN102430105B (en) | Traditional Chinese medicine composite for treating chronic gastritis | |
| CN103816497A (en) | Traditional Chinese medicinal composition for treating syndrome of liver qi stagnation | |
| CN103800880A (en) | Traditional Chinese medicine composition for treating spleen and kidney yang-deficiency disease | |
| CN103735994A (en) | Traditional Chinese medicine composition for treating stomachache | |
| CN103550684B (en) | A kind of Chinese medicine composition for the treatment of stomach carbuncle | |
| CN103550548B (en) | A kind of Chinese medicine composition for the treatment of constipation | |
| CN104771657A (en) | Traditional Chinese medicine composition for treating gastric ulcer | |
| CN103816470A (en) | Traditional Chinese medicine composition for treating anorexia | |
| CN104888132A (en) | Traditional Chinese medicine composition for treatment of chronic gastritis | |
| CN105250858A (en) | Traditional Chinese medicine composition for treating atrophic gastritis | |
| CN103816469A (en) | Chinese medicinal composition for treating deficiency of spleen and kidneys | |
| CN104758826A (en) | Traditional Chinese medicine composition for treating abdominal distension | |
| CN103800881A (en) | Traditional Chinese medicine composition for treating heart-spleen deficiency syndrome | |
| CN103550690A (en) | Traditional Chinese medicine composition for treating superficial gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140528 |
|
| WD01 | Invention patent application deemed withdrawn after publication |